Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland

British Journal of Cancer

Volumn 104, Issue 4, 2011, Pages 571-577

  Bennett, R L ^a   Sellars, S J ^b   Moss, S M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

breast cancer; interval cancer; mammography screening

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PRIORITY JOURNAL; UNITED KINGDOM;

AGED; ALGORITHMS; BREAST NEOPLASMS; CARCINOMA; DELAYED DIAGNOSIS; EARLY DETECTION OF CANCER; ENGLAND; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; NORTHERN IRELAND; PERIODICITY; PROGRAM EVALUATION; REGISTRIES; TIME FACTORS; WALES;

EID: 79951671050     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.3     Document Type: Article

References (27)

1. Advisory Committee on Breast Cancer Screening (2006) Screening for breast cancer in England: Past and Future. NHS Cancer Screening Programmes: Sheffield
2. Bates T, Kearins O, Monypenny I, Lagord C, Lawrence G (2009) Clinical outcome data for symptomatic breast cancer: the Breast Cancer Clinical Outcome Measures (BCCOM) Project. Br J Cancer 101: 395-402
3. Bennett RL, Blanks RG, Moss SM (2009) Evaluation of extension of breast screening to women aged 65-70 in England using screening perfor-mance measures. Br J Cancer 100: 1043-1047
4. Bennett RL, Blanks RG, Patnick J, Moss SM (2007) Results from the UK NHS breast screening programme 2000-05. J Med Screen 14: 200-204 (Pubitemid 350223784)
5. Beral V, Peto R (2010) UK cancer survival statistics. BMJ 341: c4112
6. Blanks RG, Day NE, Moss SM (1996) Monitoring the performance of breast screening programmes: use of indirect standardisation in evaluating the invasive cancer detection rate. J Med Screening 3: 79-81 (Pubitemid 126736080)
7. Blanks RG, Moss SM, Patnick J (2000) Results from the UK NHS breast screening programme 1994-1999. J Med Screening 7: 195-198 (Pubitemid 32099057)
8. Bulliard JL, Sasieni P, Klabunde C, De Landtsheer JP, Yankaskas BC, Fracheboud J (2006) Methodological issues in international comparison of interval breast cancers. Int J Cancer 119: 1158-1163 (Pubitemid 44116926)
9. Chamberlain J, Moss SM, Kirkpatrick AE, Michell M, Johns L (1993) National Health Service breast screening programme results for 1991-2. BMJ 307: 353-356 (Pubitemid 23224191)
10. Day N, McCann J, Camilleri-Ferrante C, Britton P, Hurst G, Cush S, Duffy S, on behalf of the Quality Assurance Management Group of the East Anglian Breast Screening Programme (1995) Monitoring interval cancers in breast screening programmes: the East Anglian experience. J Med Screening2: 180-185
11. Duffy S, Blamey RW (2008) Long-term mortality results from the UK Breast Screening Frequency Trial. Eur J Cancer Suppl (EBCC-6, European Breast Cancer Conference Berlin, Germany 15-19 April 2008) 6, pp ii, 48
12. Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, van Ineveld BM, Broeders MJ, de Bruyn AE, van der Maas PJ (1999) Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 81: 912-917 (Pubitemid 29504707)
13. Hofvind S, Yankaskas BC, Bulliard JL, Klabunde CN, Fracheboud J (2009) Comparing interval breast cancer rates in Norway and North Carolina: results and challenges. J Med Screen 16: 131-139
14. Lawrence G, O'Sullivan E, Kearins O, Tappenden N, Martin K, Wallis M (2009) Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: variation with time and impact on 10-year survival. J Med Screen 16: 186-192
15. Moss S, Blanks R (1998) Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Interval Cancer Working Group. J Epidemiol Community Health 52: 111-115 (Pubitemid 28056823)
16. Moss SM, Michel M, Patnick J, Johns L, Blanks R, Chamberlain J (1995) Results from the NHS breast screening programme 1990-1993. J Med Screening 2: 186-190
17. NHS Breast Screening Programme and Association of Breast Surgery at BASO (2010) An Audit of Screen Detected Breast Cancers for the Year of Screening April 2008 to March 2009. NHS Breast Screening Programme: Sheffield NHS Breast Screening Radiologists Quality Assurance Committee (2005) Quality Assurance Guidelines for Breast Cancer Screening Radiology. NHSBSP Publications: Sheffield
18. NHS Cancer Screening Programmes (2007) Breast Interval Cancer Manual. NHS Cancer Screening Programmes: Sheffield
19. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von karsa L (2006) European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. 4th edn. European Commission: Luxembourg
20. The NHS Information Centre (2010) Breast Screening Programme, England: 2008-09. The NHS Information Centre: Leeds.
21. The NHS Information Centre: Leeds Tornberg S, Kemetli L, Ascunce N, Hofvind S, Anttila A, Seradour B, Paci E, Guldenfels C, Azavedo E, Frigerio A, Rodrigues V, Ponti A (2010) A pooled analysis of interval cancer rates in six European countries. Eur J Cancer Prev 19: 87-93
22. United Kingdom Association of Cancer Registries (2009) UKACR Quality and Performance Indicatores 2009: Final. UKACR; http://www.ukacr.org
23. Waller M, Moss S, Watson J, Moller H (2007) The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev 16: 2257-2261 (Pubitemid 351196357)
24. Wang H, Bjurstam N, Bjorndal H, Braaten A, Eriksen L, Skaane P, Vitak B, Hofvind S, Thoresen SO (2001) Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT. Int J Cancer 94: 594-598
25. Warren R, Duffy S (2000) Interval cancers as an indicator of performance in breast screening. Breast Cancer 7: 9-18
26. Watson J, Wise L, Green J (2007) Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol 63: 843-849 (Pubitemid 47237896)
27. Woodman CBJ, Threlfall A, Boggis CRM, Prior P (1995) Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ 310: 224-226